Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
First-in-human trial naar oraal vectorvaccin tegen hiv-1
dec 2018 | HIV, Vaccinatie, Virale infecties